Improving Lives for Less
*New data* The 2015 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system $254 billion in 2014. For the first time, this year’s report features state-by-state savings, therapy area and public program savings and more. Data compiled by the IMS Institute for Healthcare Informatics. learn more >
Value and Quality
The Biosimilars Council, a division of
the Generic Pharmaceutical Association (GPhA), works to ensure a positive environment for patient access to biosimilar medicines.
Click here for more information.